{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:50:41Z","timestamp":1794095441862,"version":"4.8.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Berna\/Crucell"},{"name":"Wyeth\/Pfizer"},{"name":"MSD"},{"name":"Protea"},{"name":"GSK"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T02:32:31Z","timestamp":1368671551000},"page":"133-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"title":["Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects"],"prefix":"10.1016","volume":"32","author":[{"given":"Stephanie M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Deloria-Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilina T.","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.005_bib0005","unstructured":"Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. World Health Organization; 2012 March [accessed online 02.06.12] at http:\/\/www.who.int\/immunization_monitoring\/burden\/Pneumo_hib_estimates\/en\/index.html."},{"issue":"May (10)","key":"10.1016\/j.vaccine.2013.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/infdis\/jis240","article-title":"Aging population and future burden of pneumococcal pneumonia in the United States","volume":"205","author":"Wroe","year":"2012","journal-title":"J Infect Dis"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2013.05.005_bib0015","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.vaccine.2006.09.008","article-title":"The preventable burden of pneumococcal disease in the developing world","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.005_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.005_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"9381","key":"10.1016\/j.vaccine.2013.05.005_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet British Edition"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0035","series-title":"Pneumococcal vaccines: the impact of conjugate vaccines.","article-title":"Nasopharyngeal carriage","author":"O\u2019Brien","year":"2008"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2013.05.005_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"36","key":"10.1016\/j.vaccine.2013.05.005_bib0045","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014Unites States, 1998\u20132003","volume":"54","year":"2005","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age-groups in the United States","volume":"2","author":"Simonsen","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0055","unstructured":"Global Vaccine Introduction Status. Vaccine Information Management System (VIMS). Accelerated Vaccine Initiative March, 2013 report. Johns Hopkins Bloomberg School of Public Health. http:\/\/www.jhsph.edu\/research\/centers-and-institutes\/ivac\/vims\/IVAC-VIMS-Report-2013-03.pdf."},{"key":"10.1016\/j.vaccine.2013.05.005_bib0060","series-title":"WHO Expert Committee on Biological Standardization, 60th meeting of the WHO Expert Committee on Biological Standardization","article-title":"Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines","year":"2009"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.005_bib0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anticapsular immunoglobulin G concerntrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0075","series-title":"Second international symposium on pneumococci pneumococcal diseases","article-title":"Density of nasopharyngeal colonization (NP-col) of vaccine-type and non-vaccine type pneumococci after administration of 9-valent CRM pneumococcal conjugate vaccine, abstr. P97","author":"Fraser","year":"2000"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.005_bib0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"Pneumococcal Carriage Group (PneumoCarr). The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2013.05.005_bib0085","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.vaccine.2006.09.011","article-title":"Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine","volume":"25","author":"Isaacman","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0090","article-title":"Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules","author":"Loo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0095","unstructured":"WHO vaccine preventable diseases monitoring system: immunization schedules by antigen, Selection Centre [accessed 05.02.11] at http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/ScheduleResult.cfm."},{"key":"10.1016\/j.vaccine.2013.05.005_bib0100","unstructured":"Vaccine Information Management System [accessed March, 2011] at https:\/\/apps4.jhsph.edu\/Vaccine\/Login.aspx?ReturnUrl=%2fVaccine%2fDefault.aspx."},{"key":"10.1016\/j.vaccine.2013.05.005_bib0105","article-title":"Effect of pneumococcal conjugate vaccine dosing schedule on immunogenicity: a systematic review","author":"Deloria-Knoll","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0110","article-title":"Systematic review of the effects of pneumococcal vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children world-wide, 1994\u20132011","author":"Conklin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0115","article-title":"Systematic review of pneumococcal conjugate vaccine dosing schedules on pneumonia","author":"Loo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0120","article-title":"Differential effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage: a systematic review","author":"Fleming-Dutra","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"April (Suppl 1)","key":"10.1016\/j.vaccine.2013.05.005_bib0125","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1093\/ije\/dyq036","article-title":"CHERG Review Groups on Intervention Effects. Standards for CHERG reviews of intervention effects on child survival","volume":"39","author":"Walker","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.inf.0000148930.41928.0d","article-title":"Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults","volume":"24","author":"Shafinoori","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.05.005_bib0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/498745","article-title":"Trends in invasive pneumococcal disease-associated hospitalizations","volume":"42","author":"Shah","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1532-5415.2009.02658.x","article-title":"Declining incidence of nonbacteremic pneumococcal pneumonia in hospitalized elderly patients at a tertiary care hospital after the introduction of pneumococcal vaccines in Taiwan, 2004\u20132008","volume":"58","author":"Lin","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0150","series-title":"Abstract presented at international symposium on pneumococci and pneumococcal diseases","article-title":"Trends in serotypes among cases of invasive pneumococcal disease (IPD) in Scotland after introduction of PCV7","author":"Flasche","year":"2010"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.005_bib0155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings","volume":"22","author":"Givon","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.005_bib0160","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings","volume":"28","author":"Cheung","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1469-0691.2009.02775.x","article-title":"Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine","volume":"15","author":"Sa-Leao","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1574-695X.2007.00283.x","article-title":"Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine","volume":"51","author":"Dias","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.005_bib0175","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.05.005_bib0180","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/651680","article-title":"Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease","volume":"50","author":"Weatherholtz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0185","series-title":"Abstract 3-122 presented at the 6th international symposium on pneumococci and pneumococcal diseases","article-title":"Invasive pneumococcal disease\u2014initial impact of the conjugate vaccine in the Oxfordshire region of the UK","author":"Foster","year":"2008"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0190","series-title":"Abstract PO10.26 presented at 5th international symposium on pneumococci and pneumococcal disease","article-title":"Serotype replacement in invasive Streptococcus pneumoniae infections after introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in Canada: Implications for an expanded 13-valent conjugate vaccine","author":"Kellner","year":"2006"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0195","series-title":"Abstract presented at the 7th international symposium on pneumococci and pneumococcal diseases","article-title":"Herd immunity among adults as a consequence of the national immunization programme with pneumococcal conjugate vaccine for children in Germany","author":"Van der Linden","year":"2010"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.05.005_bib0205","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1293.2009.00717.x","article-title":"Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease","volume":"10","author":"Grau","year":"2009","journal-title":"HIV Med"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.005_bib0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10096-008-0693-1","article-title":"Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of theheptavalent pneumococcal conjugate vaccine","volume":"28","author":"Perez-Trallero","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.005_bib0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1469-0691.2008.02031.x","article-title":"Changes in Streptococcus pneumonia serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine","volume":"14","author":"Aguiar","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.005_bib0220","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/jac\/dkn413","article-title":"Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?","volume":"62","author":"Fenoll","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0225","series-title":"Abstract presented at 7th international symposium on pneumococci and pneumococcal diseases","article-title":"Changes in the serotype distribution of invasive pneumococci after introduction of the PCV7 in Denmark October 2007","author":"Lambertsen","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.005_bib0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/infdis\/jir730","article-title":"Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities","volume":"205","author":"Scott","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diagmicrobio.2011.09.006","article-title":"Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumonia before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong","volume":"71","author":"Ho","year":"2011","journal-title":"Diag Microb Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0240","doi-asserted-by":"crossref","DOI":"10.3201\/eid1704.101115","article-title":"Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands","author":"Spijkerman","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QAI.0b013e31823d0f5f","article-title":"Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children","volume":"59","author":"Burgos","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0250","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5694\/j.1326-5377.2010.tb03965.x","article-title":"Invasive pneumococcal disease in non-indigenous people in north Queensland, 2001\u20132009","volume":"193","author":"Hanna","year":"2010","journal-title":"Med J Australia"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0255","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2011.12.119","article-title":"Pneumococcal disease in South Australia: vaccine success but no time for complacency","volume":"30","author":"Johnson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0260","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial Meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.005_bib0265","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03404065","article-title":"The epidemiology of invasive pneumococcal disease in British Columbia following implementation of an infant immunization program: increases in herd immunity and replacement disease","volume":"103","author":"Sahni","year":"2012","journal-title":"Can J Public Health"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0275","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/INF.0b013e3182624a40","article-title":"Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta","volume":"31","author":"Leal","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0280","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0285","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2012.06.068","article-title":"Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children","volume":"30","author":"Van der Linden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0290","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1016\/j.vaccine.2012.03.060","article-title":"Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme","volume":"30","author":"Ingels","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0295","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3182152bf1","article-title":"Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay","volume":"30","author":"Pirez","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0300","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1016\/j.vaccine.2011.05.082","article-title":"The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumonia, in the top end of the Northern Territory, Australia \u2013 over 22 years","volume":"29","author":"Jacups","year":"2011","journal-title":"Vaccine"},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2013.05.005_bib0305","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","article-title":"Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity","volume":"23","author":"Hennessy","year":"2005","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2013.05.005_bib0310","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.005_bib0315","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.005_bib0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5694\/j.1326-5377.2006.tb00149.x","article-title":"Invasive pneumococcal disease in Indigenous people in north Queensland, 1999\u20132004","volume":"184","author":"Hanna","year":"2006","journal-title":"Med J Australia"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.005_bib0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5694\/j.1326-5377.2008.tb01897.x","article-title":"Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005\u20132007","volume":"189","author":"Hanna","year":"2008","journal-title":"Med J Australia"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0330","series-title":"Abstract presented at 3rd international symposium on pneumococci and pneumococcal disease","article-title":"Is use of conjugate pneumococcal vaccine changing invasive pneumococcal disease among Navajo and White Mountain Apache populations?","author":"O\u2019Brien","year":"2002"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0335","series-title":"Abstract PO4.17 presented at 5th international symposium on pneumococci and pneumococcal disease","article-title":"Replacement invasive pneumococcal disease 9 years after introduction of PCV use among a population at high risk for IPD: the Navajo experience","author":"O\u2019Brien","year":"2006"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0340","series-title":"Abstract SY2.05 presented at 5th international symposium on pneumococci and pneumococcal disease","article-title":"Preventing pneumococcal disease in the White Mountain Apache American Indian community","author":"Craig","year":"2006"},{"issue":"20","key":"10.1016\/j.vaccine.2013.05.005_bib0345","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.vaccine.2009.02.063","article-title":"Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998\u20132006)","volume":"27","author":"Gil","year":"2009","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2013.05.005_bib0350","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1016\/j.vaccine.2009.03.063","article-title":"Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000\u20132006","volume":"27","author":"Tyrrell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0355","series-title":"Abstracts of the interscience conference on antimicrobial agents & chemotherapy, vol. 48","first-page":"386","article-title":"Decline in invasive pneumococcal disease in the U.S. in 2000: An effect of pneumococcal conjugate vaccine?","author":"Whitney","year":"2001"},{"issue":"3 Pt 1","key":"10.1016\/j.vaccine.2013.05.005_bib0360","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0365","series-title":"Abstract PO4.04 presented at the 5th international symposium on pneumococci and pneumococcal disease","article-title":"Invasive pneumococcal disease and the impact of the 7-valent pneumococcal conjugate vaccine in the greater Sydney region NSW 1998\u20132005","author":"McIntyre","year":"2006"},{"issue":"August (35)","key":"10.1016\/j.vaccine.2013.05.005_bib0370","first-page":"1","article-title":"Impact of pneumococcal vaccination on invasive pneumococcal diseases in France, 2001\u20132006","volume":"13","author":"Lepoutre","year":"2008","journal-title":"Eur Surveill"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0375","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/adc.2007.119891","article-title":"Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France","volume":"92","author":"Dubos","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0380","series-title":"8th international symposium on pneumococci and pneumococcal disease","article-title":"A multi-site analysis of serotype-specific changes in invasive pneumococcal disease after conjugate vaccine introduction among children <5 years old","author":"Feikin","year":"2012"},{"key":"10.1016\/j.vaccine.2013.05.005_bib0385","first-page":"434","article-title":"Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report","volume":"43","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"9807","key":"10.1016\/j.vaccine.2013.05.005_bib0390","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"9568","key":"10.1016\/j.vaccine.2013.05.005_bib0395","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:23Z","timestamp":1759400423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13005616"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}